Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | METAP1 | P53582 | 1/20 | 0.31 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.30 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22612192 | 0.84 | OPRM1 (0.50) | OPRM1PLA2G1BPLA2G2A | |
| SCHEMBL3459174 | 0.79 | ALDH1A1 (0.30) | — | |
| SCHEMBL187299 | 0.76 | PLA2G1B (0.33) | OPRM1METAP1PLA2G1BPLA2G2A | |
| SCHEMBL3237512 | 0.74 | FDPS (0.36) | OPRM1METAP1PLA2G1BPLA2G2A | |
| SCHEMBL15668478 | 0.73 | HTT (0.32) | — | |
| SCHEMBL3460907 | 0.70 | OPRM1 (0.38) | OPRM1METAP1 | |
| SCHEMBL3460398 | 0.70 | PLA2G1B (0.39) | OPRM1PLA2G1BPLA2G2A | |
| SCHEMBL9716803 | 0.70 | TSHR (0.35) | — | |
| SCHEMBL3461429 | 0.69 | MAPK1 (0.35) | — | |
| SCHEMBL8806714 | 0.69 | OPRM1 (0.35) | OPRM1METAP1PLA2G1BPLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107540565-B | Preparation of N, N- (di) alkylaminoalkyl (meth) acrylamides or the corresponding esters and quaternary ammonium salts thereof | 赢创运营有限公司 | 2022-10-21 | — | — | CN | disclosed |
| US-8674133-B2 | Method for continuously producing alkylamino(meth)acrylamides | EVONIK RÖHM GMBH (DE) | 2014-03-18 | — | — | US | disclosed |
| US-20110313195-A1 | METHOD FOR CONTINUOUSLY PRODUCING ALKYLAMINO(METH)ACRYLAMIDES | EVONIK ROEHM GMBH (DE) | 2011-12-22 | — | — | US | disclosed |
| US-7723543-B2 | Method for the continuous production of alkyl amino acryl amides | EVONIK ROEHM GMBH (DE) | 2010-05-25 | — | — | US | disclosed |
| US-7586004-B2 | Method for continuously producing alkylamino(meth)acrylamides | ROEHM GMBH & CO. KG (DE) | 2009-09-08 | — | — | US | disclosed |
| US-20090149674-A1 | METHOD FOR THE CONTINUOUS PRODUCTION OF ALKYL AMINO ACRYL AMIDES | ROEHM GMBH (DE) | 2009-06-11 | — | — | US | disclosed |
| US-20070149811-A1 | Method for continuously producing alkylamino(meth)acrylamides | ROEHM GMBH & CO. KG (DE) | 2007-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110313195-A1 | METHOD FOR CONTINUOUSLY PRODUCING ALKYLAMINO(METH)ACRYLAMIDES | ACR, TET2, PAM | OPRM1 2173/4885METAP1 443/4885PLA2G1B 2634/4885 |
| US-20090149674-A1 | METHOD FOR THE CONTINUOUS PRODUCTION OF ALKYL AMINO ACRYL AMIDES | ACR, NAAA, AANAT | OPRM1 4198/4885METAP1 1626/4885PLA2G1B 1194/4885 |
| US-20070149811-A1 | Method for continuously producing alkylamino(meth)acrylamides | ACR, MMAB, TET2 | OPRM1 2128/4885METAP1 522/4885PLA2G1B 3381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.